Following the firm’s $1.75bn acquisition of radiopharmaceuticals company Mariana Oncology and the $745m deal with Ratio ...

Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its immune cell expansion ...

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

AstraZeneca’s Truqap (capivasertib) has been approved for use by the National Health Service (NHS) in England and Wales, ...

Belief BioMed (BBM) and Takeda China have announced the receipt of China’s NMPA approval for BBM-H901for treating haemophilia ...

AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.

Biocon Biologics has received approval from the US Food and Drug Administration for the intravenous use of Jobevne ...

On 7 April, at the 2025 American Academy of Neurology (AAN) meeting, a poster presentation by the Peking Union Medical ...

The biotech has launched a strategic review to consider options, including a possible sale, following shareholder pressure.

The UK's MHRA has been redesignated as one of the WHO’s collaborating centres for the standardisation and evaluation of ...

APHA executive director Dr Georges C Benjamin has called for HHS secretary Robert F Kennedy, Jr (RFK Jr) to "resign or be ...